[Cytomegalovirus retinitis after highly active antiretroviral therapy: a case report].
METHODS
An HIV infected patient with cytomegalovirus retinitis with a CD4 lymphocyte count of 498 cells/mm3 after a good response to highly active antiretroviral therapy is described.


CONCLUSIONS
Some aspects of the immune system after highly active antiretroviral therapy remain unknown. CD4 T lymphocyte count might not be a good marker to identify some patients at risk of developing cytomegalovirus retinitis after this therapy.
Andonegui Navarro
J
J
Hospital de Txagorritxu, Vitoria, Alava, España.
Aldamiz-Etxebarría
M
M
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy / Q000821:virology; D000328:Adult; D023241:Antiretroviral Therapy, Highly Active; D000998:Antiviral Agents / Q000627:therapeutic use; D018791:CD4 Lymphocyte Count; D017726:Cytomegalovirus Retinitis / Q000188:drug therapy; D016049:Didanosine / Q000627:therapeutic use; D015774:Ganciclovir / Q000627:therapeutic use; D015658:HIV Infections / Q000188:drug therapy; D017320:HIV Protease Inhibitors / Q000627:therapeutic use; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use; D008297:Male; D012166:Retinal Hemorrhage / Q000209:etiology; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use; D012306:Risk; D019258:Saquinavir / Q000627:therapeutic use; D018119:Stavudine / Q000627:therapeutic use; D015819:Substance Abuse, Intravenous; D015215:Zidovudine / Q000627:therapeutic use
D000998:Antiviral Agents; D017320:HIV Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine; D015215:Zidovudine; D018119:Stavudine; D016049:Didanosine; D019258:Saquinavir; D015774:Ganciclovir